Sjögren's syndrome historical perspective

Jump to navigation Jump to search

Sjögren's syndrome Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sjögren's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sjögren's syndrome historical perspective On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sjögren's syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sjögren's syndrome historical perspective

CDC on Sjögren's syndrome historical perspective

Sjögren's syndrome historical perspective in the news

Blogs on Sjögren's syndrome historical perspective

Directions to Hospitals Treating Sjögren's syndrome

Risk calculators and risk factors for Sjögren's syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]

Overview

In 1892, Johann von Mikulicz-Radecki was to first to describe a patient with with enlargement of the parotid and lacrimal glands associated with a round-cell infiltrate and acinar atrophy. In 1933, Henrik Sjögren was the first to describe 19 females with clinical and pathological manifestations of the Sjögren's syndrome.

Historical Perspective

Discovery

  • In 1892, Johann von Mikulicz-Radecki was to first to describe a patient with enlargement of the parotid and lacrimal glands associated with a round-cell infiltrate and acinar atrophy.[1]
  • In 1933, Henrik Sjögren was the first to describe 19 females with clinical and pathological manifestations of the Sjögren's syndrome.
  • In 1951, Sjögren published a paper describing 80 patients with keratoconjunctivitis sicca associated with Sjögren's syndrome.
  • In 1976, the first symposium on Sjogren's syndrome was held in Sweden.[2]
  • In 1980, autoantibodies to the centromere proteins (CENP) were found in 40% of patients with Sjögren's syndrome.[3]

References

  1. Talal N (August 1992). "Sjögren's syndrome: historical overview and clinical spectrum of disease". Rheum. Dis. Clin. North Am. 18 (3): 507–15. PMID 1496158.
  2. Bjelle, A. (1987). "Historical Perspective: The Early Years (1930–1960)": 3–6. doi:10.1007/978-3-642-50118-0_1.
  3. Fritzler, Marvin J.; Rattner, Jerome B.; Luft, LeeAnne M.; Edworthy, Steven M.; Casiano, Carlos A.; Peebles, Carol; Mahler, Michael (2011). "Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F". Autoimmunity Reviews. 10 (4): 194–200. doi:10.1016/j.autrev.2010.09.025. ISSN 1568-9972.